Seyffert, J., and W. Steffes. “Vitiligo Following Alemtuzumab Therapy in Multiple Sclerosis: A Demonstration of Secondary Autoimmunity”. International Journal of Research in Dermatology, vol. 5, no. 4, Oct. 2019, pp. 882-4, doi:10.18203/issn.2455-4529.IntJResDermatol20194687.